(Q44487780)

3 December 2017

title

Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus (English)

1 reference

3 December 2017

1 reference

Emre Yildirim

1 reference

3 December 2017

Zhijing Zhang

1 reference

3 December 2017

Tolga Uz

1 reference

3 December 2017

Chang-qing Chen

1 reference

3 December 2017

Radmila Manev

1 reference

3 December 2017

Hari Manev

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

345

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

141-143

1 reference

Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Getting balance: drugs for bipolar disorder share target

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Transcription. Unlocking the gates to gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Putative role of neuronal 5-lipoxygenase in an aging brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Histone deacetylases as therapeutic targets in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Regulation of chromatin structure by site-specific histone H3 methyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

Histone acetylation and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

The 5-lipoxygenase promoter is regulated by DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

5-Lipoxygenase is required for proliferation of immature cerebellar granule neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

A common mechanism of action for three mood-stabilizing drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900490-7

7 January 2021

10.1016/S0304-3940(03)00490-7

Identifiers

DOI

1 reference

3 December 2017

1 reference